US Patent Issued to LION TCR on Sept. 1 for "HBV specific TCR library and its use as personalised medicine" (Singaporean Inventors)

ALEXANDRIA, Va., Sept. 1 -- United States Patent no. 12,723,328, issued on Sept. 1, was assigned to LION TCR PTE. LTD. (Singapore).

"HBV specific TCR library and its use as personalised medicine" was invented by Antonio Bertoletti (Singapore), Zi Zong Ho (Singapore), Sarene Koh (Singapore), Anthony Tanoto Tan (Singapore) and Lu-En Wai (Singapore).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides T cell receptors (TCRs) that bind Hepatitis B virus (HBV) antigens. The present invention also provides methods of producing, screening and selecting the TCRs, therapeutic applications of the TCRs, and libraries of the TCRs."

The patent was filed on Jan. 21, 2021, under Application No. 17/794,379....